Novartis In Society Us Report

Overview

The report describes Novartis's 2020 US efforts to strengthen diversity, inclusion, health equity and participation in clinical trials. It highlights long-term climate, water and waste targets, including an ambition for carbon-neutral operations. The report also records significant patient-access support, with NPAF providing more than USD 3.3 billion in free medicines to more than 107 000 patients. It further reports broad research, innovation and COVID-19 response activity across the US business.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services